Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1955 1
1956 2
1957 1
1959 1
1960 3
1961 1
1965 5
1966 12
1967 12
1968 28
1969 10
1970 21
1971 15
1972 18
1973 10
1974 15
1975 23
1976 23
1977 22
1978 23
1979 20
1980 17
1981 24
1982 26
1983 36
1984 49
1985 40
1986 42
1987 54
1988 52
1989 71
1990 64
1991 101
1992 81
1993 83
1994 89
1995 94
1996 81
1997 83
1998 78
1999 79
2000 100
2001 90
2002 89
2003 131
2004 105
2005 100
2006 123
2007 127
2008 134
2009 154
2010 164
2011 184
2012 204
2013 208
2014 176
2015 196
2016 212
2017 201
2018 205
2019 204
2020 243
2021 287
2022 301
2023 301
2024 84

Text availability

Article attribute

Article type

Publication date

Search Results

5,296 results

Results by year

Filters applied: . Clear all
Page 1
Neuroblastoma.
Chung C, Boterberg T, Lucas J, Panoff J, Valteau-Couanet D, Hero B, Bagatell R, Hill-Kayser CE. Chung C, et al. Pediatr Blood Cancer. 2021 May;68 Suppl 2(Suppl 2):e28473. doi: 10.1002/pbc.28473. Pediatr Blood Cancer. 2021. PMID: 33818884 Free PMC article. Review.
Immunotherapy of Neuroblastoma: Facts and Hopes.
Anderson J, Majzner RG, Sondel PM. Anderson J, et al. Clin Cancer Res. 2022 Aug 2;28(15):3196-3206. doi: 10.1158/1078-0432.CCR-21-1356. Clin Cancer Res. 2022. PMID: 35435953 Free PMC article. Review.
Overview and recent advances in the treatment of neuroblastoma.
Whittle SB, Smith V, Doherty E, Zhao S, McCarty S, Zage PE. Whittle SB, et al. Expert Rev Anticancer Ther. 2017 Apr;17(4):369-386. doi: 10.1080/14737140.2017.1285230. Epub 2017 Mar 15. Expert Rev Anticancer Ther. 2017. PMID: 28142287 Free article. Review.
Advances in neuroblastoma therapy.
MacFarland S, Bagatell R. MacFarland S, et al. Curr Opin Pediatr. 2019 Feb;31(1):14-20. doi: 10.1097/MOP.0000000000000711. Curr Opin Pediatr. 2019. PMID: 30480556 Review.
Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1.
Mabe NW, Huang M, Dalton GN, Alexe G, Schaefer DA, Geraghty AC, Robichaud AL, Conway AS, Khalid D, Mader MM, Belk JA, Ross KN, Sheffer M, Linde MH, Ly N, Yao W, Rotiroti MC, Smith BAH, Wernig M, Bertozzi CR, Monje M, Mitsiades CS, Majeti R, Satpathy AT, Stegmaier K, Majzner RG. Mabe NW, et al. Nat Cancer. 2022 Aug;3(8):976-993. doi: 10.1038/s43018-022-00405-x. Epub 2022 Jul 11. Nat Cancer. 2022. PMID: 35817829 Free PMC article.
Neuroblastoma and Stem Cell Therapy: An Updated Review.
Gupta MK, Mallepalli S, Damu A, Vadde R. Gupta MK, et al. CNS Neurol Disord Drug Targets. 2021;20(7):625-643. doi: 10.2174/1871527319666201102100911. CNS Neurol Disord Drug Targets. 2021. PMID: 33138765 Review.
Neuroblastoma: an ongoing cold front for cancer immunotherapy.
Kennedy PT, Zannoupa D, Son MH, Dahal LN, Woolley JF. Kennedy PT, et al. J Immunother Cancer. 2023 Nov 22;11(11):e007798. doi: 10.1136/jitc-2023-007798. J Immunother Cancer. 2023. PMID: 37993280 Free PMC article. Review.
5,296 results